Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis

PURPOSE: To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC). METHODS: This open-label nonrandomized clinical trial evaluated 33 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Fang, Zang, Yunxiao, Sella, Ruti, Lu, Hongshuang, Li, Shang, Yang, Ke, Jin, Tao, Afshari, Natalie A., Pan, Zhiqiang, Jie, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766164/
https://www.ncbi.nlm.nih.gov/pubmed/31637051
http://dx.doi.org/10.1155/2019/3143469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766164/
https://www.ncbi.nlm.nih.gov/pubmed/31637051
http://dx.doi.org/10.1155/2019/3143469

Ejemplares similares